Calidi Biotherapeutics, Inc. Fair Value Adjustment of Warrants
Calidi Biotherapeutics, Inc. (CLDI) reported Fair Value Adjustment of Warrants of $1.28 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-21.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2023-08-21
- Calidi Biotherapeutics, Inc. fair value adjustment of warrants for the quarter ending 2023-06-30 was $1.28M.
- Calidi Biotherapeutics, Inc. fair value adjustment of warrants for the quarter ending 2023-03-31 was -$88.50K.
- Calidi Biotherapeutics, Inc. fair value adjustment of warrants for the quarter ending 2022-12-31 was -$140.00K.
- Calidi Biotherapeutics, Inc. fair value adjustment of warrants for the quarter ending 2022-09-30 was -$460.00K.
- Calidi Biotherapeutics, Inc. fair value adjustment of warrants for fiscal 2022 was -$6.72M.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2023-06-30 | $1.28M 10-Q · filed 2023-08-21 | $1.19M 10-Q · filed 2023-08-21 | $1.05M derived: sum of 3 quarters · filed 2023-08-21 | $592.00K derived: sum of 4 quarters · filed 2023-08-21 |
| 2023-03-31 | -$88.50K 10-Q · filed 2023-05-15 | -$228.50K derived: sum of 2 quarters · filed 2023-05-15 | -$688.50K derived: sum of 3 quarters · filed 2023-05-15 | -$4.72M derived: sum of 4 quarters · filed 2023-08-21 |
| 2022-12-31 | -$140.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$600.00K derived: sum of 2 quarters · filed 2023-03-31 | -$4.63M derived: sum of 3 quarters · filed 2023-08-21 | -$6.72M 10-K · filed 2023-03-31 |
| 2022-09-30 | -$460.00K 10-Q · filed 2022-11-14 | -$4.49M derived: sum of 2 quarters · filed 2023-08-21 | -$6.58M 10-Q · filed 2022-11-14 | -$11.96M derived: sum of 4 quarters · filed 2023-08-21 |
| 2022-06-30 | -$4.03M 10-Q · filed 2023-08-21 | -$6.12M 10-Q · filed 2023-08-21 | -$11.49M derived: sum of 3 quarters · filed 2023-08-21 | -$11.78M derived: sum of 4 quarters · filed 2023-08-21 |
| 2022-03-31 | -$2.09M 10-Q · filed 2023-05-15 | -$7.47M derived: sum of 2 quarters · filed 2023-05-15 | -$7.75M derived: sum of 3 quarters · filed 2023-05-15 | -$7.75M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$5.37M derived: 10-K 9 month − 10-Q 6 month · filed 2023-03-31 | -$5.65M derived: sum of 2 quarters · filed 2023-03-31 | -$5.65M 10-K · filed 2023-03-31 | |
| 2021-09-30 | -$283.00K 10-Q · filed 2022-11-14 | -$283.00K 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |